{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:20:28Z","timestamp":1793337628255,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jchf.2024.08.017","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T14:56:21Z","timestamp":1728485781000},"page":"554-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Efficacy, Safety and Mechanistic Impact of a Heart\u00a0Failure Guideline-Directed Medical Therapy Clinic"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9157-5648","authenticated-orcid":false,"given":"Aferdita","family":"Spahillari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura P.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Tringale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Khairnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin M.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.","family":"Wasfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita S.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3192-8093","authenticated-orcid":false,"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2024.08.017_bib1","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2024.08.017_bib2","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2022.05.033","article-title":"Cardiovascular disease projections in the United States based on the 2020 census estimates","volume":"80","author":"Mohebi","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib4","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14163","article-title":"2023 focused update of the 2021 ESC heart failure guidelines: key messages for clinical practice","volume":"54","author":"Tomasoni","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jchf.2024.08.017_bib6","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"83","author":"Maddox","year":"2024","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib7","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamacardio.2023.1266","article-title":"Contemporary use of sodium-glucose cotransporter-2 inhibitor therapy among patients hospitalized for heart failure with reduced ejection fraction in the US: The Get With The Guidelines-Heart Failure Registry","volume":"8","author":"Pierce","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.cardfail.2022.02.011","article-title":"Medical therapy during hospitalization for heart failure with reduced ejection fraction: the VICTORIA Registry","volume":"28","author":"Greene","year":"2022","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2024.08.017_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry","volume":"72","author":"Greene","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2024.08.017_bib12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamacardio.2020.0640","article-title":"Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the GUIDE-IT trial: a secondary analysis of a randomized clinical trial","volume":"5","author":"Fiuzat","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamacardio.2023.5627","article-title":"Interventions for optimization of guideline-directed medical therapy: a systematic review","volume":"9","author":"Tang","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib14","unstructured":"Candidates certified-all candidates. American Board of Internal Medicine. Accessed August 14, 2024. https:\/\/www.abim.org\/Media\/vaqdilmh\/candidates-certified-all-candidates.pdf."},{"key":"10.1016\/j.jchf.2024.08.017_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijcard.2021.09.013","article-title":"Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: observations from The Swedish Heart\u00a0Failure Registry","volume":"343","author":"Kapelios","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"8","key":"10.1016\/j.jchf.2024.08.017_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jchf.2024.03.001","article-title":"Eligibility and projected benefits of rapid initiation of quadruple medical therapy for newly diagnosed heart failure","volume":"12","author":"Greene","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2024.08.017_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jchf.2023.04.017","article-title":"Mortality, outcomes, costs, and use of medicines following a first heart failure hospitalization: EVOLUTION HF","volume":"11","author":"Bozkurt","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2024.08.017_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-8703(99)70253-X","article-title":"Self-reported differences between cardiologists and heart failure specialists in the management of chronic heart failure","volume":"138","author":"Bello","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2024.08.017_bib20","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.jacc.2019.03.464","article-title":"Reasons for lack of improvement in treatment with evidence-based therapies in heart failure","volume":"73","author":"Bozkurt","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jacc.2023.05.050","article-title":"Bridging treatment implementation gaps in patients with heart failure: JACC focus seminar 2\/3","volume":"82","author":"Jalloh","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.jchf.2024.08.017_bib22","article-title":"Clinician perceptions and reasons for non-use of guideline-directed medical therapy for heart failure with reduced ejection fraction in the United States","volume":"44","author":"Gulea","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.08.017_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamacardio.2019.4987","article-title":"Patient perceptions and familiarity with medical therapy for heart failure","volume":"5","author":"Samsky","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib24","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ejheart.2008.08.001","article-title":"Cardiologists' awareness and perceptions of guidelines for chronic heart failure. The ADDress your Heart survey","volume":"10","author":"Erhardt","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.jchf.2024.08.017_bib25","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/ejhf.3267","article-title":"Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: first data from the TITRATE-HF study","volume":"26","author":"Malgie","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.08.017_bib26","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2024.08.017_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/CIRCOUTCOMES.116.003086","article-title":"Clinical interventions to reduce preventable hospital readmission after percutaneous coronary intervention","volume":"9","author":"Tanguturi","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2024.08.017_bib28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","article-title":"Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach","volume":"56","author":"Kramer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.08.017_bib29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1161\/CIRCULATIONAHA.122.061693","article-title":"Association between sacubitril\/valsartan initiation and mitral regurgitation severity in heart failure with reduced ejection fraction: the PROVE-HF Study","volume":"146","author":"Januzzi","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.08.017_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.121.054034","article-title":"Implantable cardioverter-defibrillator eligibility after initiation of sacubitril\/valsartan in chronic heart failure: insights from PROVE-HF","volume":"144","author":"Felker","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.08.017_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacc.2020.11.008","article-title":"Randomized trial of empagliflozin in nondiabetic patients with heart failure and reduced ejection fraction","volume":"77","author":"Santos-Gallego","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.jchf.2024.08.017_bib32","first-page":"S31","article-title":"Ejection fraction improvement by beta-blocker treatment in patients with heart failure: an analysis of studies published in the literature","volume":"32","author":"van Campen","year":"1998","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jchf.2024.08.017_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5455\/medarh.2023.77.105-111","article-title":"The effectiveness of eplerenone vs spironolactone on left ventricular systolic function, hospitalization and cardiovascular death in patients with chronic heart failure-HFrEF","volume":"77","author":"Naser","year":"2023","journal-title":"Med Arch"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924006231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924006231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:45:05Z","timestamp":1775022305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177924006231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2213177924006231"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2024.08.017","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, Safety and Mechanistic Impact of a Heart\u00a0Failure Guideline-Directed Medical Therapy Clinic","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2024.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}